Emergent Biosolutions EBS Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $676.8M-29.9% | $742.9M-28.8% | $788.9M-29.9% | $851.6M-22.7% | $965.4M-18.6% | ||
| $309.7M-50.5% | $326.2M-52.1% | $359.3M-52.0% | $396M-50.7% | $625.2M-10.3% | ||
| $367.1M+7.9% | $416.7M+15.0% | $429.6M+13.9% | $455.6M+52.1% | $340.2M-30.3% | ||
| 54.2%+19.0pp | 56.1%+21.4pp | 54.5%+21.0pp | 53.5%+26.3pp | 35.2%-6.0pp | ||
| $48.6M-31.3% | $53.2M-24.8% | $50.2M-44.8% | $50.5M-45.4% | $70.7M-17.6% | ||
| $180.3M-34.6% | $186.1M-39.6% | $195.8M-41.9% | $233.5M-32.6% | $275.7M-21.6% | ||
| $65.3M+0.2% | $65.1M0.0% | $65.1M+0.2% | $65.1M+0.2% | $65.2M+0.6% | ||
| $616.1M-42.1% | $642.8M-44.2% | $670.4M-47.2% | $745.1M-52.0% | $1.06B-38.3% | ||
| —— | —— | $118.5M+183% | $106.5M+124% | -$98.6M+81.7% | ||
| $55.6M-9.4% | $59.3M-16.5% | $59.4M-23.7% | $52.5M-41.2% | $61.4M-34.9% | ||
| -$57.2M-258% | -$17.3M+49.4% | -$12.6M+53.0% | $84.2M+166% | $36.3M+286% | ||
| $12.2M+0.8% | $0-100% | -$12.2M— | $52.1M— | $12.1M— | ||
| —— | —— | $105.9M+162% | $190.7M+133% | -$62.3M+88.8% | ||
| $12.1M-82.5% | $30.2M-36.7% | $30M— | $51.2M— | $69.3M— | ||
| —— | —— | $75.9M+136% | $139.5M+124% | -$131.6M+76.7% | ||
| —— | —— | $1.31+133% | $2.46+122% | -$2.70+75.3% | ||
| —— | —— | $1.42+136% | $2.62+123% | -$2.54+76.8% | ||
| 223.9M+2.5% | 224.7M+5.3% | 221M+4.4% | 220.1M+5.9% | 218.5M+6.1% | ||
| 212.8M-0.1% | 215.3M+2.1% | 214.8M+2.7% | 214.7M+3.3% | 213.1M+3.5% | ||
| $65.3M+0.2% | $65.1M0.0% | $65.1M+0.2% | $65.1M+0.2% | $65.2M+0.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $676.8M-29.9% | $742.9M-28.8% | $788.9M-29.0% | $851.6M-21.1% | $965.4M-11.2% | ||
| —— | —— | $118.5M+183% | $106.5M+124% | -$98.6M+81.7% | ||
| —— | —— | $216.8M+808% | $207.8M+162% | $7.7M+102% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Emergent Biosolutions's revenue?
- Emergent Biosolutions (EBS) generated $676.8M in revenue over the trailing twelve months, down 29.9% year over year.
- Is Emergent Biosolutions profitable?
- Emergent Biosolutions reported $114.0M in net income over the trailing twelve months, a 9.6% net margin.
- What are Emergent Biosolutions's profit margins?
- Gross margin is 54.2% and operating margin is 15.0%, with a 9.6% net margin.
- What is Emergent Biosolutions's earnings per share?
- Emergent Biosolutions's diluted EPS over the trailing twelve months is $1.95.
- Where does Emergent Biosolutions's income statement data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
